Deferiprone: differenze tra le versioni

Versione delle 23:31, 2 feb 2019

Versione delle 23:40, 30 apr 2019

Riga 48:

Sono stati pubblicati a tutto giugno 2010 più di 650 lavori che parlano di deferiprone; tra essi vi sono 4 [[metanalisi]] rilevanti:

* ''Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation''<ref name="pmid19068191">{{Cita pubblicazione | autore = McLeod C, Fleeman N, Kirkham J, ''et al.'' | titolo = Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation | rivista = Health Technology Assessment (Winchester, England) | volume = 13 | numero = 1 | pp = iii–iv, ix–xi, 1–121 | anno = 2009 | mese = gennaio | pmid = 19068191 | doi = 10.3310/hta13010 | url = http://www.hta.ac.uk/execsumm/summ1301.htm | accesso = 9 luglio 2010 | urlmorto = sì | urlarchivio = https://web.archive.org/web/20100726214855/http://www.hta.ac.uk/execsumm/summ1301.htm | dataarchivio = 26 luglio 2010 }}</ref>

* ''Oral deferiprone for iron chelation in people with thalassaemia''<ref name="pmid17636775">{{Cita pubblicazione | autore = Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ | titolo = Oral deferiprone for iron chelation in people with thalassaemia | rivista = Cochrane Database of Systematic Reviews (Online) | numero = 3 | pp = CD004839 | anno = 2007 | pmid = 17636775 | doi = 10.1002/14651858.CD004839.pub2 | url = httphttps://dx.doi.org/10.1002/14651858.CD004839.pub2 | accesso=9 luglio 2010}}</ref>

* ''Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia''<ref name="pmid16235363">{{Cita pubblicazione | autore = Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S | titolo = Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia | rivista = Cochrane Database of Systematic Reviews (Online) | numero = 4 | pp = CD004450 | anno = 2005 | pmid = 16235363 | doi = 10.1002/14651858.CD004450.pub2 | url = httphttps://dx.doi.org/10.1002/14651858.CD004450.pub2 | accesso=9 luglio 2010}}</ref>

* ''Meta-analytic review of the clinical effectiveness of oral deferiprone (L1)''<ref name="pmid10206077">{{Cita pubblicazione| autore=Addis A, Loebstein R, Koren G, Einarson TR| titolo=Meta-analytic review of the clinical effectiveness of oral deferiprone (L1). | rivista=Eur J Clin Pharmacol | anno= 1999 | volume= 55 | numero= 1 | pp=1-6 | pmid=10206077 | url=httphttps://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10206077 }}</ref>

== Controindicazioni ==